Cargando…
MON-500 A Case of Tumor-Induced Osteomalacia Caused by Metastatic Prostate Cancer
Background: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by severe hypophosphatemia due to renal phosphate wasting. An overproduction of the phosphatonin fibroblast growth factor 23 (FGF-23) has been implicated in TIO pathogenesis. FGF-23 increases renal phosphate...
Autores principales: | Rahman, Wedad, Whitlatch, Hilary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550874/ http://dx.doi.org/10.1210/js.2019-MON-500 |
Ejemplares similares
-
MON-501 A Hemangioma Causing Tumor Induced Osteomalacia
por: Chinnakotla, Venkata Sai Bhavana, et al.
Publicado: (2019) -
ODP125 Soft Bones in Crohn's: Tumor-induced osteomalacia and inflammatory bowel disease
por: Habbsa, Samima, et al.
Publicado: (2022) -
Tumor Induced Osteomalacia in Patients With Metastatic Prostate Cancer: Case Report and Literature Review
por: Khadilkar, Arjun, et al.
Publicado: (2021) -
MON-352 When Osteoporosis Does Not Make Sense: Tumor-Induced Osteomalacia
por: Techathaveewat, Pawarid, et al.
Publicado: (2020) -
MON-502 It's Not Always Osteoporosis: FGF-23 Induced Osteomalacia
por: Bello Segura, Manuel, et al.
Publicado: (2019)